title: Prophylactic administration of a combined prebiotic and probiotic, or therapeutic administration of enrofloxacin, to reduce the incidence of bacterial chondronecrosis with osteomyelitis in broilers.
abstract: Bacteria entering the bloodstream via translocation from the gastrointestinal tract spread hematogenously and can trigger bacterial chondronecrosis with osteomyelitis (BCO) by infecting osteochondrotic microfractures in the epiphyseal-physeal cartilage of the proximal femora and tibiae. In experiment 1, broilers were fed control feed or the same feed containing BacPack 2X, which includes the prebiotic IMW50 (a mannan oligosaccharide beta-glucan yeast cell wall product) plus the probiotic Calsporin (Bacillus subtilis C-3102). Broilers reared on wire flooring consistently developed higher incidences of BCO than hatchmates reared on wood shavings litter (≥24 vs. ≤4%, respectively; P=0.001). Adding BacPack 2X to the feed on d 1 through 56 delayed the age of onset and reduced the cumulative incidence of BCO on wire flooring when compared with broilers fed the control feed (24.0 vs. 40.7%, respectively; P=0.003). In experiment 2, broilers reared on wire flooring received tap water on d 1 through 62 (control group) or therapeutic levels of the potent fluoroquinolone antimicrobial enrofloxacin in the water on d 35 through 54 (enrofloxacin group). During enrofloxacin administration, half as many birds developed BCO in the enrofloxacin group when compared with the control group (8.1 vs. 19.5%, respectively, on d 35 through 54; P=0.001), whereas both groups had similar BCO incidences subsequent to withdrawing enrofloxacin on d 55 through 62 (14.8 vs. 18.2% for the enrofloxacin vs. control groups; P=0.386). Cumulative lameness incidences for d 1 through 62 were higher for the control group than for the enrofloxacin group (39.0 vs. 25.8%, respectively; P=0.003). These results demonstrate that wire flooring imposes a rigorous challenge that leads to high incidences of BCO that can be difficult to suppress, even with therapeutic doses of enrofloxacin. Prophylactically adding BacPack 2X to the feed reduced the incidence of BCO lameness by a proportion similar to that achieved with enrofloxacin, indicating that probiotics potentially can provide effective alternatives to antibiotics for reducing BCO lameness attributable to bacterial translocation and hematogenous distribution.
authors.affiliation: University of Arkansas, Division of Agriculture, Fayetteville 72701 rwideman@uark.edu.
authors.forename: R F
authors.initials: RF
authors.lastname: Wideman
authors.affiliation: University of Arkansas, Department of Biological Sciences, Fayetteville 72701.
authors.forename: A
authors.initials: A
authors.lastname: Al-Rubaye
authors.affiliation: University of Arkansas, Division of Agriculture, Fayetteville 72701.
authors.forename: Y M
authors.initials: YM
authors.lastname: Kwon
authors.affiliation: University of Arkansas, Division of Agriculture, Fayetteville 72701.
authors.forename: J
authors.initials: J
authors.lastname: Blankenship
authors.affiliation: University of Arkansas, Division of Agriculture, Fayetteville 72701.
authors.forename: H
authors.initials: H
authors.lastname: Lester
authors.affiliation: University of Arkansas, Division of Agriculture, Fayetteville 72701.
authors.forename: K N
authors.initials: KN
authors.lastname: Mitchell
authors.affiliation: Cobb-Vantress Inc., Siloam Springs, AR 72761.
authors.forename: I Y
authors.initials: IY
authors.lastname: Pevzner
authors.affiliation: Quality Technology International, Inc., Elgin, IL 60123.
authors.forename: T
authors.initials: T
authors.lastname: Lohrmann
authors.affiliation: Quality Technology International, Inc., Elgin, IL 60123.
authors.forename: J
authors.initials: J
authors.lastname: Schleifer
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis / Q000662:veterinary*; D002645:Chickens; D000077422:Enrofloxacin; D005430:Floors and Floorcoverings; D024841:Fluoroquinolones / Q000627:therapeutic use; D006799:Housing, Animal; D015994:Incidence; D007794:Lameness, Animal / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D008297:Male; D009336:Necrosis / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology / Q000662:veterinary; D010019:Osteomyelitis / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology / Q000662:veterinary*; D011201:Poultry Diseases / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D056692:Prebiotics / Q000032:analysis; D019936:Probiotics / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D056692:Prebiotics; D000077422:Enrofloxacin
keywords: broiler; lameness; osteomyelitis; prebiotic; probiotic